First case of lenvatinib-induced pyoderma gangrenosum: Possible management with dose reduction

Akihiro Miyagawa; Takeya Adachi; Saeko Takamiyagi; Hiroki Arakawa; Misako Matsushita; Toyoko Inazumi

doi:10.1111/1346-8138.15829

First case of lenvatinib-induced pyoderma gangrenosum: Possible management with dose reduction

Akihiro Miyagawa, Takeya Adachi, Saeko Takamiyagi, Hiroki Arakawa, Misako Matsushita, Toyoko Inazumi

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e221-e222
Journal	Journal of Dermatology
Volume	48
Issue number	5
DOIs	https://doi.org/10.1111/1346-8138.15829
Publication status	Published - 2021 May
Externally published	Yes

ASJC Scopus subject areas

Dermatology

Access to Document

10.1111/1346-8138.15829

Cite this

@article{13e672b1c01c45c6a243b0f60a2bd90c,

title = "First case of lenvatinib-induced pyoderma gangrenosum: Possible management with dose reduction",

author = "Akihiro Miyagawa and Takeya Adachi and Saeko Takamiyagi and Hiroki Arakawa and Misako Matsushita and Toyoko Inazumi",

note = "Funding Information: This study was supported by the Scientific Research Fund of the Ministry of Health, Labor, and Welfare, Japan (201913009A). Our special gratitude goes to Dr Hajime Iizuka (Research Institute of Psoriasis, Sapporo, Japan) for his valuable suggestions regarding the manuscript. Funding Information: This study was supported by the Scientific Research Fund of the Ministry of Health, Labor, and Welfare, Japan (201913009A). Our special gratitude goes to Dr Hajime Iizuka (Research Institute of Psoriasis, Sapporo, Japan) for his valuable suggestions regarding the manuscript.",

year = "2021",

month = may,

doi = "10.1111/1346-8138.15829",

language = "English",

volume = "48",

pages = "e221--e222",

journal = "Journal of Dermatology",

issn = "0385-2407",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - First case of lenvatinib-induced pyoderma gangrenosum

T2 - Possible management with dose reduction

AU - Miyagawa, Akihiro

AU - Adachi, Takeya

AU - Takamiyagi, Saeko

AU - Arakawa, Hiroki

AU - Matsushita, Misako

AU - Inazumi, Toyoko

N1 - Funding Information: This study was supported by the Scientific Research Fund of the Ministry of Health, Labor, and Welfare, Japan (201913009A). Our special gratitude goes to Dr Hajime Iizuka (Research Institute of Psoriasis, Sapporo, Japan) for his valuable suggestions regarding the manuscript. Funding Information: This study was supported by the Scientific Research Fund of the Ministry of Health, Labor, and Welfare, Japan (201913009A). Our special gratitude goes to Dr Hajime Iizuka (Research Institute of Psoriasis, Sapporo, Japan) for his valuable suggestions regarding the manuscript.

PY - 2021/5

Y1 - 2021/5

UR - http://www.scopus.com/inward/record.url?scp=85101867415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85101867415&partnerID=8YFLogxK

U2 - 10.1111/1346-8138.15829

DO - 10.1111/1346-8138.15829

M3 - Letter

C2 - 33651422

AN - SCOPUS:85101867415

SN - 0385-2407

VL - 48

SP - e221-e222

JO - Journal of Dermatology

JF - Journal of Dermatology

IS - 5

ER -

First case of lenvatinib-induced pyoderma gangrenosum: Possible management with dose reduction

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this